Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |